SERB COVID-19 Short-Term Core Research Grant – Applications Invited
Short-term Core Research Grant Special Call on COVID-19. COVID-19 SERB Call For Proposals. Interested and eligible applicants can check out all of the details on the same below:
This Call Expires In :
SCIENCE AND ENGINEERING RESEARCH BOARD
Short-term Core Research Grant special call on COVID-19
(April 2, 2020)
Considering emerging health care requirements to combat the COVID-19 epidemic,
SERB announces rapid/short-term projects in the following thrust areas, preferably
with multidisciplinary efforts:
- Antiviral nanomaterials and bionano antiviral systems
- Drug repurposing against key COVID-19 targets
- Affordable, portable rapid diagnostic kits/tools
- Computational identification and validation of COVID-19 molecular targets
- In-vitro/clinical dose testing of nutritional supplements for immunity
Project duration should be up to 1 year with a maximum budget limit of Rs. 25 lakhs
(including overhead). Proposals should be submitted through the SERB online portal
(www.serbonline.in) in Core Research Grant (CRG) format. Proposals will be initially
screened for the competence of PI, suitability and scope prior to peer-review.
Projects concerning other pathogens will not be considered in this call.
Projects will be evaluated on the first-come basis, with a last date of submission is April 30,
2020.
Contact Details:
Dr. T. Thangaradjou, Scientist E (All bio / bionano related Queries)
Email: [email protected]
Tel: 011-40000345 (availability subject to lockdown rules)
Dr. Arvind Chaudhary, Scientist C (All chemistry and nano related Queries)
Email: [email protected]
Tel: 011-40000381 (availability subject to lockdown rules)
View Notification Below
Editor’s Note: SERB COVID-19 Short-Term Core Research Grant – Applications Invited. Please make sure that you are subscribed to the Biotecnika Times Newsletter and our YouTube channel to be notified of all of the latest in the industry. Follow us on all of our social media like Twitter, Facebook and Instagram.
